(lp0
S'Sangamo Therapeutics Receives Orphan Drug Designation from the FDA for SB-913 ... PR Newswire  - Mar 1, 2017 RICHMOND, Calif., March 1, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. , the leader in therapeutic genome editing, announced today that the U.S.'
p1
aS'Sangamo Therapeutics Announces Presentation At The Cowen And Company 37th ... PR Newswire  - Mar 1, 2017 RICHMOND, Calif., March 1, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. , the leader in therapeutic genome editing, announced today that Sandy Macrae, M.B.'
p2
aS'Sangamo Therapeutics Reports Fourth Quarter And Full Year 2016 Financial Results PR Newswire  - Feb 28, 2017 &quot;Early this year we rebranded our company as Sangamo Therapeutics, underscoring our focus on clinical development of genomic therapies using our industry leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy,&quot;&nbsp;...SANGAMO THERAPEUTICS, INC.  Files An 8-K Results of Operations ... - Market Exclusive'
p3
aS'Sangamo Therapeutics Announces Fourth Quarter And Full Year 2016 Conference ... PR Newswire  - Feb 21, 2017 RICHMOND, Calif., Feb. 21, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. , the leader in therapeutic genome editing, announced today that the company will release its fourth quarter and full year 2016 financial results before the market&nbsp;...'
p4
aS'Sangamo Therapeutics Receives Rare Pediatric Disease Designation From FDA For ... PR Newswire  - Feb 27, 2017 RICHMOND, Calif., Feb. 27, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. , the leader in therapeutic genome editing, today announced that the U.S.Sangamo  Announces Rare Pediatric Disease Designation From FDA For SB-318 - StreetInsider.com'
p5
aS'Sangamo BioSciences Changes Name To Sangamo Therapeutics, Underscoring Focus ... PR Newswire  - Jan 6, 2017 RICHMOND, Calif., Jan. 6, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. , the leader in therapeutic genome editing, announces that it has changed its corporate name, from &quot;Sangamo BioSciences, Inc.&quot; to &quot;Sangamo Therapeutics, Inc.&quot;&nbsp;...'
p6
aS'Sangamo Therapeutics Presents Latest Advances In Zinc Finger Nuclease Platform ... PR Newswire  - Jan 10, 2017 RICHMOND, Calif., Jan. 10, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. , the leader in therapeutic genome editing, today announced the presentation of key improvements to its technology platform for engineering highly specific zinc&nbsp;...'
p7
aS"BRIEF-Sangamo Therapeutics announces CFO succession Reuters - Feb 27, 2017 SANTIAGO, March 11 The striking union at BHP Billiton's Escondida copper mine in Chile, the world's largest, told Reuters on Saturday that it will not accept an offer from the company to return to the negotiating table, and it called on the company to ..."
p8
aS'SANGAMO THERAPEUTICS, INC.  Files An 8-K Departure of Directors ... Market Exclusive - Feb 25, 2017 On February 21, 2017, Dr. Dale Ando and Sangamo Therapeutics, Inc.  entered into a separation agreement .'
p9
aS'Sangamo Therapeutics Announces Upcoming Presentations At The 13th Annual ... PR Newswire  - Feb 8, 2017 RICHMOND, Calif., Feb. 8, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. , the leader in therapeutic genome editing, today announced upcoming oral and poster presentations at the 13th Annual WORLDSymposium Meeting being&nbsp;...'
p10
a.